The leading players that launched their key products in the second half of 2021 include Bayer, Albireo Pharma, Sanofi, Takeda, Mirum Pharmaceuticals, Novartis, AOP Orphan, On Target Laboratories, argenx, Amgen, AstraZeneca, Leo Pharma, and others.